130 related articles for article (PubMed ID: 34265498)
1. Endoscopic Cyclophotocoagulation in Boston Keratoprosthesis Type II.
Xu C; Chen TC; Chodosh J; Eliott D; Mukai S; Shen LQ; Vavvas DG; Young LH; Lin MM
Ophthalmol Glaucoma; 2022; 5(1):120-123. PubMed ID: 34265498
[No Abstract] [Full Text] [Related]
2. Endoscopic Cyclophotocoagulation for the Treatment of Glaucoma in Boston Keratoprosthesis Type II Patient.
Poon LY; Chodosh J; Vavvas DG; Dohlman CH; Chen TC
J Glaucoma; 2017 Apr; 26(4):e146-e149. PubMed ID: 28079656
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic cyclophotocoagulation in osteo-odonto-keratoprosthesis (OOKP) eyes.
Lee RM; Al Raqqad N; Gomaa A; Steel DH; Bloom PA; Liu CS
J Glaucoma; 2011 Jan; 20(1):68-9; author reply 69. PubMed ID: 21191275
[No Abstract] [Full Text] [Related]
4. Cyclophotocoagulation in the Control of Glaucoma in Patients With the Boston Keratoprosthesis Type 1.
Jabbour S; Harissi-Dagher M; Agoumi Y; Singh H; Robert MC
Cornea; 2020 Feb; 39(2):181-185. PubMed ID: 31335536
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of the Boston type 1 and the Aurolab keratoprosthesis in eyes with limbal stem cell deficiency.
Shanbhag SS; Senthil S; Mohamed A; Basu S
Br J Ophthalmol; 2021 Apr; 105(4):473-478. PubMed ID: 32554443
[TBL] [Abstract][Full Text] [Related]
6. Challenges in management of the Boston Keratoprosthesis Type 1.
Koo EH; Hannush SB
Curr Opin Ophthalmol; 2021 Jul; 32(4):385-388. PubMed ID: 33973907
[TBL] [Abstract][Full Text] [Related]
7. Type 1 Boston Keratoprosthesis for Limbal Stem Cell Deficiency in Epidermolysis Bullosa.
Sravani NG; Mohamed A; Sangwan VS
Ocul Immunol Inflamm; 2019; 27(2):282-284. PubMed ID: 29099638
[No Abstract] [Full Text] [Related]
8. Glaucoma and keratoprosthesis surgery: role of adjunctive cyclophotocoagulation.
Rivier D; Paula JS; Kim E; Dohlman CH; Grosskreutz CL
J Glaucoma; 2009; 18(4):321-4. PubMed ID: 19365199
[TBL] [Abstract][Full Text] [Related]
9. Design and Outcomes of a Novel Keratoprosthesis: Addressing Unmet Needs in End-Stage Cicatricial Corneal Blindness.
Bakshi SK; Graney J; Paschalis EI; Agarwal S; Basu S; Iyer G; Liu C; Srinivasan B; Chodosh J
Cornea; 2020 Apr; 39(4):484-490. PubMed ID: 31724985
[TBL] [Abstract][Full Text] [Related]
10. Expanding indications for the Boston keratoprosthesis.
Colby KA; Koo EB
Curr Opin Ophthalmol; 2011 Jul; 22(4):267-73. PubMed ID: 21537184
[TBL] [Abstract][Full Text] [Related]
11. Ultra-Widefield Fundus Images are a Better Exploratory Technique than Indirect Ophthalmoscopy in Patients with a Type 1 Boston Keratoprosthesis.
Velez-Montoya R; Meizner-Grezemkovsky D; Sanchez-Huerta V; Cabrera E; Jimenez-Sierra JM; De Wit-Carter G; Hernandez-Quintela E; Salcedo-Villanueva G
Ophthalmol Retina; 2020 Jun; 4(6):645-647. PubMed ID: 32387051
[No Abstract] [Full Text] [Related]
12. Comment on Bilateral Boston keratoprosthesis type 1 in a case of severe Mooren's ulcer.
Geoffrion D; Harissi-Dagher M
Eur J Ophthalmol; 2022 Jan; 32(1):NP297-NP298. PubMed ID: 32551901
[No Abstract] [Full Text] [Related]
13. [The Boston keratoprosthesis].
Wang L; Huang Y; James C; Dohlman CH
Zhonghua Yan Ke Za Zhi; 2014 Apr; 50(4):307-12. PubMed ID: 24931158
[TBL] [Abstract][Full Text] [Related]
14. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
Pujari S; Siddique SS; Dohlman CH; Chodosh J
Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
[TBL] [Abstract][Full Text] [Related]
15. Endoscopy-assisted total pars plana vitrectomy during Boston keratoprosthesis type 1 implantation.
Geoffrion D; Mullie GA; Arej N; Rhéaume MA; Harissi-Dagher M
Can J Ophthalmol; 2023 Oct; 58(5):e209-e211. PubMed ID: 37059120
[No Abstract] [Full Text] [Related]
16. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
Aldave AJ; Kamal KM; Vo RC; Yu F
Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
[TBL] [Abstract][Full Text] [Related]
17. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year Clinical Outcomes in 134 Cases of Bilateral Corneal Blindness.
Basu S; Serna-Ojeda JC; Senthil S; Pappuru RR; Bagga B; Sangwan V
Am J Ophthalmol; 2019 Sep; 205():175-183. PubMed ID: 30905723
[TBL] [Abstract][Full Text] [Related]
18. Boston type 1 keratoprosthesis: the New York Eye and Ear experience.
Patel AP; Wu EI; Ritterband DC; Seedor JA
Eye (Lond); 2012 Mar; 26(3):418-25. PubMed ID: 22173079
[TBL] [Abstract][Full Text] [Related]
19. Response to Letter to the Editor: Comment on Bilateral Boston Keratoprosthesis Type I in a case of severe Mooren's ulcer.
Eur J Ophthalmol; 2022 Sep; 32(5):NP95. PubMed ID: 35369791
[No Abstract] [Full Text] [Related]
20. Results from the multicenter Boston Type 1 Keratoprosthesis Study.
Zerbe BL; Belin MW; Ciolino JB;
Ophthalmology; 2006 Oct; 113(10):1779.e1-7. PubMed ID: 16872678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
